TABLE 1.
Overview of vaccine adjuvant formulations
| Adjuvant | Formulation |
|---|---|
| Advax1 | Inulin polysaccharide adjuvant alone with no TLR agonist |
| Advax2 | Advax1 + 10 μg TLR9 agonist (CpG55.2) |
| Advax3 | Aldeltin (special formulation containing alum OH) + 10 μg TLR9 agonist (CpG55.2) |
| Advax4 | Advax1 + 10 ng TLR7/8 agonist |
| Advax5 | Advax1 + 200 ng TLR4 agonist |
| Advax6 | Advax1 + 5 μg TLR3 agonist |
| Advax7 | Advax1 + 5 μg TLR2 agonist |
| Advax8 | Advax1 + 1 μg TLR4 agonist (5 times more TLR4 agonist than Advax5) |
| Advax9 | Inulin polysaccharide alone with no TLR agonist-improved antigen binding capacity vs Advax1 |